Zhitong Finance App News, Baiyunshan (00874.HK) announced that on December 22, 2025, the board of directors approved the signing of partnership agreements 1 between Guangzhou Pharmaceutical Phase II Fund, a subsidiary of the company, and Guangzhou Pharmaceutical Capital and Guangkai Fund. According to this, Guangzhou Pharmaceutical Phase II Fund, Guangzhou Pharmaceutical Capital, and Guangkai Fund invested RMB 97.50 million, RMB 2.50 million, and RMB 100 million respectively to participate in the establishment of the Guangzhou Pharmaceutical Guangkai Fund.

Zhitong Finance App News, Baiyunshan (00874.HK) announced that on December 22, 2025, the board of directors approved the signing of partnership agreements 1 between Guangzhou Pharmaceutical Phase II Fund, a subsidiary of the company, and Guangzhou Pharmaceutical Capital and Guangkai Fund. According to this, Guangzhou Pharmaceutical Phase II Fund, Guangzhou Pharmaceutical Capital, and Guangkai Fund invested RMB 97.50 million, RMB 2.50 million, and RMB 100 million respectively to participate in the establishment of the Guangzhou Pharmaceutical Guangkai Fund.